semaglutide compounding pharmacy ban Regulator acts to close loophole enabling Australian pharmacists to make copycat Ozempic drug Novo Nordisk asks FDA to

Learn more about the Affinity team Michael Koehler, MD Affinity's Medical Director Real patients , real results Started my journey on December 9, 2023

No, commercial GLP-1 patches cant replace weight loss injections

The starting dose (0.25 mg) is intentionally low to minimize side effects and let your body adjust

The maths is laid out for you in the calculator above

Novo Nordisk is down 50% due to competition from Eli Lilly, and Eli Lilly is down 15% due to Novo Nordisk & rising price competition

Namely: No longer covering GLP-1s for weight loss : Several insurers have made the choice to stop providing coverage for these drugs when used specifically for weight loss, while still covering them for other uses like diabetes